Zoetis (ZTS) Change in Taxes (2014 - 2026)
Zoetis (ZTS) posted quarterly Change in Taxes of $73.0 million for Q1 2026, down 29.81% year-over-year from $104.0 million in Q1 2025, and up 108.57% quarter-over-quarter from $35.0 million in Q4 2025.
Zoetis (ZTS) Change in Taxes (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Taxes for 13 consecutive years, with $73.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Taxes fell 29.81% year-over-year to $73.0 million; the TTM figure through Mar 2026 stood at $30.0 million (up 176.92% YoY), while the FY2025 annual figure was $61.0 million, up 458.82% from the prior year.
- Change in Taxes improved to $73.0 million in Q1 2026 per ZTS's latest filing, from $35.0 million in the prior quarter.
- Across five years, Change in Taxes topped out at $126.0 million in Q1 2024 and bottomed at -$168.0 million in Q2 2023.
- Historically, Change in Taxes has averaged $10.6 million across 5 years, with a median of $35.0 million in 2025.
- Annual changes were most pronounced in 2023 — Change in Taxes slumped 145.61% — and 2025, when it jumped 600.0%.
- Zoetis' Change in Taxes stood at $57.0 million in 2022, then plunged by 145.61% to -$26.0 million in 2023, then soared by 73.08% to -$7.0 million in 2024, then surged by 600.0% to $35.0 million in 2025, then surged by 108.57% to $73.0 million in 2026.
- Business Quant data shows ZTS's Change in Taxes at $73.0 million in Q1 2026, $35.0 million in Q4 2025, and $54.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.44 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.00 Mn |
| Jun 30, 2026 | -66.00 Mn |
| Mar 31, 2026 | 73.00 Mn |
| Mar 31, 2026 | 73.00 Mn |
| Dec 31, 2025 | 35.00 Mn |
| Dec 31, 2025 | 35.00 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Jun 30, 2025 | -132.00 Mn |
| Jun 30, 2025 | -132.00 Mn |
| Mar 31, 2025 | 104.00 Mn |
| Mar 31, 2025 | 104.00 Mn |
| Dec 31, 2024 | -7.00 Mn |
| Dec 31, 2024 | -7.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | -156.00 Mn |
| Jun 30, 2024 | -156.00 Mn |
| Mar 31, 2024 | 126.00 Mn |
| Mar 31, 2024 | 126.00 Mn |